Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4682272

CCOC(=O)c1ccc(NC(=N)N)s1.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.56
HDAC6 Q9UBN7 2/20 0.56
HDAC3 O15379 1/20 0.56
HDAC1 Q13547 1/20 0.56
AR P10275 4/20 0.44
P2RY1 P47900 1/20 0.42
NR3C1 P04150 2/20 0.42
TRPM8 Q7Z2W7 1/20 0.40
ALDH1A1 P00352 7/20 0.40
HPGD P15428 7/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 4/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4685876 0.81 DAO (0.45) HDAC4HDAC6HDAC3HDAC1ALDH1A1
SCHEMBL4685880 0.78 HDAC4 (0.35) HDAC4HDAC6HDAC3HDAC1P2RY1
SCHEMBL10530362 0.75 HDAC3 (0.54) HDAC4HDAC6HDAC3HDAC1AR
SCHEMBL8704326 0.74 HDAC3 (0.50) HDAC4HDAC6HDAC3HDAC1AR
SCHEMBL7257673 0.73 HDAC3 (0.55) HDAC4HDAC6HDAC3HDAC1AR
SCHEMBL2296183 0.72 HDAC6 (1.00) HDAC4HDAC6HDAC3HDAC1ALDH1A1
Trifluoroacetic Acid SCHEMBL28285603 0.72 HDAC3 (0.54) HDAC4HDAC6HDAC3HDAC1ALDH1A1
SCHEMBL7018973 0.71 HDAC3 (0.73) HDAC4HDAC6HDAC3HDAC1ALDH1A1
SCHEMBL3244368 0.70 HDAC4 (0.68) HDAC4HDAC6HDAC3HDAC1TRPM8
Hydrochloric Acid SCHEMBL4684147 0.70 DAO (0.42) ALDH1A1MEN1KMT2ARAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236712-B1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE AJINOMOTO KK (JP) 2008-08-06 EP disclosed
US-6710056-B2 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVE AN EXCELLENT ANTAGONISTIC EFFECT AGAINST ACTIVATED BLOOD COAGULATION FACTOR VII. AJINOMOTO CO., INC. (JP) 2004-03-23 US disclosed
US-20030109547-A1 Amidinophenylpyruvic acid derivatives AJINOMOTO CO. INC (JP) 2003-06-12 US disclosed
EP-1236712-A1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE Ajinomoto Co., Inc. (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109547-A1 Amidinophenylpyruvic acid derivatives HABP2, F2, F7 HDAC4 1268/4885HDAC6 3287/4885HDAC3 1097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.